Prisma Health establishes $3M endowment, molecular oncology research chair

South Carolina-based Prisma Health has established a $3 million endowment to go towards an endowed chair position in molecular oncology research, according to a Feb. 13 report from the Greenville Journal.

Advertisement

The endowment will honor W. Larry Gluck, MD, who will retire from his position as the medical director of Prisma Health’s Cancer Institute May 12. Dr. Gluck has been with the health system for nearly four decades.

While at Prisma Health, Dr. Gluck established a variety of research programs, including an institute for translational research, a center for integrative oncology and survivorship, and a center for cancer prevention and wellness. 

The W. Larry Chuck, MD Endowed Chair of Translational Molecular Oncology Research position will be used to fund a physician-scientist’s work, the report said.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

From fragmentation to operational flow: Solving the healthcare workforce puzzle

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenters: Dr. Pat Hunt, QGendaAndrea Daugherty, MHA, CISSP, CHCIO, CDH-E, Arrowhead Regional Medical CenterElizabeth Lindsay-Wood, MBA, CHCIO, CDH-E, Moffitt Cancer CenterDeb Muro, El Camino HealthJohn Tejeda, D.H.A., MLS, MPAS, DFAAPA, LSSBB, FACHE, Vascular and Neuroscience Institute

Advertisement

Next Up in Leadership

Advertisement

Comments are closed.